Sonoma Pharmaceuticals Inc

General ticker "SNOA" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $2.8M

Sonoma Pharmaceuticals Inc follows the US Stock Market performance with the rate: 2.4%.

Estimated limits based on current volatility of 3.3%: low 2.55$, high 2.72$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

  • 2024-03-31 to 2025-03-31 estimated range: [2.41$, 7.42$]
  • 2025-03-31 to 2026-03-31 estimated range: [2.64$, 6.61$]

Financial Metrics affecting the SNOA estimates:

  • Negative: Non-GAAP EPS, $ of -1.95 <= 0.10
  • Negative: Operating profit margin, % of -26.96 <= 1.03
  • Negative: Operating cash flow per share per price, % of -64.43 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31

Similar symbols

Short-term SNOA quotes

Long-term SNOA plot with estimates

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue $12.63MM $13.27MM $12.73MM
Operating Expenses $18.52MM $17.84MM $17.44MM
Operating Income $-5.89MM $-4.57MM $-4.70MM
Non-Operating Income $0.47MM $-0.61MM $-0.33MM
Interest Expense $0.01MM $0.02MM $0.00MM
R&D Expense $0.12MM $0.21MM $1.87MM
Income(Loss) $-5.42MM $-5.18MM $-5.03MM
Taxes $-0.33MM $-0.03MM $-0.20MM
Profit(Loss) $-5.09MM $-5.15MM $-4.83MM
Stockholders Equity $8.70MM $7.98MM $6.14MM
Inventory $2.66MM $2.86MM $2.72MM
Assets $18.84MM $16.23MM $14.74MM
Operating Cash Flow $-4.25MM $-6.15MM $-2.40MM
Capital expenditure $0.14MM $0.27MM $0.02MM
Investing Cash Flow $-0.10MM $-0.26MM $-0.00MM
Financing Cash Flow $7.40MM $2.49MM $1.68MM
Earnings Per Share* $-38.40 $-30.40 $-10.64

* EPS are Split Adjusted, recent splits may be reflected with a delay.